Bodhi Tree Biotechnology (BDTB) Equity Average (2024 - 2025)
Bodhi Tree Biotechnology (BDTB) reported Equity Average of $92687.0 for Q4 2025, down 60.8% year-over-year from $236438.5 in Q4 2024, and down 25.56% on a QoQ basis from $124504.5 in Q3 2025.
Bodhi Tree Biotechnology (BDTB) has 2 years of Equity Average data on file, last reported at $92687.0 in Q4 2025.
- Quarterly Equity Average fell 60.8% year-over-year to $92687.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $92687.0 (down 60.8% YoY) and the FY2025 annual result came in at $193994.0, changed N/A from the prior year.
- Equity Average eased to $92687.0 in Q4 2025 per BDTB's latest filing, from $124504.5 in the prior quarter.
- Across five years, Equity Average topped out at $236438.5 in Q4 2024 and bottomed at $92687.0 in Q4 2025.
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 92,687.00 |
| Sep 30, 2025 | 124,504.50 |
| Jun 30, 2025 | 140,235.00 |
| Mar 31, 2025 | 177,336.00 |
| Dec 31, 2024 | 236,438.50 |